The Top 50 Pharma Tracker

02.11.2023 | Article

Top 50 Pharma Tracker: Novavax FDA approval received positively by eHCPs

Pfizer, Moderna, Novavax, Johnson & Johnson, and AstraZeneca were the most discussed by HCPs

By Aman Jandu

01.10.2023 | Article

Top 50 Pharma Tracker: eHCPs celebrate vaccine data from Novavax and Moderna approval

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

01.09.2023 | Article

Top 50 Pharma Tracker: Novo Nordisk’s semaglutide trial gets praise from HCPs

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

11.08.2023 | Article

Top 50 Pharma Tracker: eHCP concern about drug shortages after tornado damages Pfizer facility

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

02.07.2023 | Article

Top 50 Pharma Tracker: eHCPs approve of new pharma trial data at ASCO 2023

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Aman Jandu

12.06.2023 | Article

Top 50 Pharma tracker review: The importance of knowing what HCPs think.

Looking at the corporate reputation of the Top 50 pharma companies over the past year

By Francesca Gan

01.06.2023 | Article

Top 50 Pharma Tracker: eHCPs commend pharma companies for their contributions to local communities

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Imma Tinat

01.05.2023 | Article

Top 50 Pharma Tracker: eHCPs applaud pharma collaborating with one another

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Imma Tinat

01.04.2023 | Article

Top 50 Pharma Tracker: eHCPs celebrate Eli Lilly for capping the cost of insulin

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Imma Tinat

05.01.2023 | Article

Top 50 Pharma Tracker: HCPs celebrate the Moderna and Merck combination melanoma vaccine and immunotherapy

The 5 companies mentioned the most by HCPs were Pfizer, Moderna, Johnson & Johnson....

By Francesca Gan

18.12.2022 | Article

Top 50 Pharma Tracker: HCPs actively discussed issues concerning mRNA and bivalent COVID-19 vaccines

In Nov 2022 there was a 22% decrease in HCP pharma mentions from the previous month

By Francesca Gan

14.11.2022 | Article

Top 50 Pharma Tracker: HCPs actively discussed issues concerning mRNA and bivalent COVID-19 vaccines

The FDA granted emergency use of Pfizer and Moderna's bivalent vaccine in children

By Francesca Gan